GTX-011 improves fibrosis and hepatic stellate cells phenotype in human precision cut liver slices
Andrés-Rozas M, Boyer-Diaz Z, Ruiz-Canovas E, Aristu-Zabalza P, Garcia-Delgado N, Mercade J, Bosch J, Gracia-Sancho J.
EASL Liver Congress; 2023 June 21-14; Vienna, Austria.
GTX-011 IMPROVES PORTAL HYPERTENSION, LIVER FIBROSIS AND ENDOTHELIAL DYSFUNCTION IN A RAT MODEL OF NON-ALCOHOLIC STEATOHEPATITIS
Andrés-Rozas M, Boyer-Diaz Z, Ruiz-Canovas E, Aristu-Zabalza P, Garcia-Delgado N, Mercade J, Bosch J, Gracia-Sancho J
AASLD, The Liver Meeting Digital Experience; 2021 Nov 12-15.
Introducing a new pre-clinical model of advanced NASH that mimics the main pathophysiologic characteristics and transcriptomic signature of the human disease
Maeso-Díaz R, Boyer-Diaz Z, Peralta C, Bosch J, Gracia-Sancho J.
EASL – The International Liver Congress; 2019 Apr 10-14; Vienna, Austria.
Hepatic fatty acid profile in chronic liver disease: mechanism of injury and novel therapeutic target
AASLD, The Liver Meeting; 2019 Nov 8-12; Boston, MA, United-States.
Introducing a new pre-clinical model of advanced NASH that mimics the main pathophysiologic characteristics and transcriptomic signature of the human disease
Maeso-Díaz R, Boyer-Diaz Z, Peralta C, Bosch J, Gracia-Sancho J.
EASL – The International Liver Congress; 2019 Apr 10-14; Vienna, Austria.
Molecular mechanisms underlying the beneficial effects of emricasan in portal hypertension and chronic liver disease: relevance of the hepato-sinusoidal cross-talk.
Gracia-Sancho J, Manicardi N, Ortega-Ribera M, Fernández-Iglesias A, Boyer-Diaz Z, Contreras PC, Spada A, Bosch J.
AASLD, The Liver Meeting; 2018 Nov 9-13; San Francisco, CA, United-States.
Hepatocyte maintenance in vitro using an advanced microfluidic bioreactor for biomedical research and pharmaceutical applications
BLB works toward helping our partners to accelerate the development of new chemical entities to treat human liver disease. We value talent, experience and dedication of each of our employees.
BLB seeks outstanding scientists, pharmacologists, biomedical engineers, computational biologists and business developers
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site, we will assume that you agree to it.AcceptNo
ou can revoke your consent at any time by using the consent revocation button.Revoke consent